Cardiology

Guidelines updated on duration of dual antiplatelet Tx in CAD

(HealthDay)—The American College of Cardiology and the American Heart Association Task Force on Clinical Practice Guidelines has updated the recommendations regarding duration of dual antiplatelet therapy (DAPT) for patients ...

Cardiology

Long duration dual antiplatelet treatment increases bleeding

(HealthDay)—Routine use of dual antiplatelet therapy (DAPT) beyond six months after second generation drug-eluting stent (DES) implantation yields mixed clinical results, according to a review published in the October issue ...

Cardiology

Review: Short vs. long duration dual antiplatelet Tx after stent

(HealthDay)—Dual antiplatelet therapy (DAPT) continued beyond six months after drug-eluting stent implantation is associated with reduced stent thrombosis and myocardial infarction but also increased bleeding and all-cause ...

Cardiology

Six-month dual antiplatelet tx noninferior to 24-month DAPT

(HealthDay)—For aspirin-sensitive patients undergoing everolimus-eluting stent implantation, six-month dual antiplatelet therapy (DAPT) is noninferior to 24-month DAPT, according to a study published in the March 3 issue ...

Cardiology

Cardiac risk up with noncardiac surgery six months post-stent

(HealthDay)—Among post-stent patients undergoing noncardiac surgery, the incremental risk of adverse cardiac events is highest in the first six months following stent implantation, according to a study published in the ...

Cardiology

Results of OCT STEMI trial reported at TCT 2014

The first randomized trial to examine serial optical coherence tomography (OCT) in primary percutaneous coronary intervention (PCI) was reported at the 26th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific ...

page 2 from 5